320 related articles for article (PubMed ID: 23585566)
1. Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.
Tang Z; Bereczki E; Zhang H; Wang S; Li C; Ji X; Branca RM; Lehtiö J; Guan Z; Filipcik P; Xu S; Winblad B; Pei JJ
J Biol Chem; 2013 May; 288(22):15556-70. PubMed ID: 23585566
[TBL] [Abstract][Full Text] [Related]
2. Compound C enhances tau phosphorylation at Serine
Majd S; Koblar S; Power J
Neurosci Lett; 2018 Mar; 670():53-61. PubMed ID: 29398519
[TBL] [Abstract][Full Text] [Related]
3. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
[TBL] [Abstract][Full Text] [Related]
4. Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau.
Meske V; Albert F; Ohm TG
J Biol Chem; 2008 Jan; 283(1):100-109. PubMed ID: 17971449
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
6. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
9. Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.
Zhou XW; Winblad B; Guan Z; Pei JJ
J Alzheimers Dis; 2009; 17(4):929-37. PubMed ID: 19542610
[TBL] [Abstract][Full Text] [Related]
10. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
12. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
13. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.
Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
[TBL] [Abstract][Full Text] [Related]
16. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
Zhu Y; Wang J
Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
[TBL] [Abstract][Full Text] [Related]
17. An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease.
Cavallini A; Brewerton S; Bell A; Sargent S; Glover S; Hardy C; Moore R; Calley J; Ramachandran D; Poidinger M; Karran E; Davies P; Hutton M; Szekeres P; Bose S
J Biol Chem; 2013 Aug; 288(32):23331-47. PubMed ID: 23798682
[TBL] [Abstract][Full Text] [Related]
18. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
Chatterjee S; Sang TK; Lawless GM; Jackson GR
Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]